Schizophrenia News and Research

Latest Schizophrenia News and Research

Better care needed for people experiencing first manic episode, say researchers

Better care and more research into treatments for people experiencing a first manic episode are urgently needed, according to researchers at the NIHR Maudsley Biomedical Research Centre.

25 Jun 2019

Scientists discover new drug target for chemically induced Parkinson's disease

More than three decades ago, scientists discovered that a chemical found in a synthetic opioid, MPTP, induced the onset of a form of Parkinson's disease.

23 Jun 2019

Gene associated with increased risk of cannabis abuse

New research from the Danish psychiatric project, iPSYCH, shows that a specific gene is associated with an increased risk of cannabis abuse. The gene is the source of a so-called nicotine receptor in the brain, and people with low amounts of this receptor have an increased risk of cannabis abuse.

18 Jun 2019

Georgia researcher receives grant to develop models to better predict mental health disorders

Vince Calhoun, Distinguished University Professor of Psychology at Georgia State University and director of the Center for Translational Research in Neuroimaging and Data Science, has received nearly $4 million from the National Institutes of Health's National Institute of Mental Health to develop new models that use brain imaging and genomic data to better predict mental health disorders

18 Jun 2019

Research opens up new avenues for understanding the causes of schizophrenia

Schizophrenia causes hallucinations and memory or cognition problems inter alia. This psychiatric illness affects 0.5% of the general population, and it may be related to genetic abnormalities of chromosome 22, known as 22q11 deletion syndrome.

17 Jun 2019

New machine-learning method more precisely quantifies a known indicator for psychosis

A machine-learning method discovered a hidden clue in people's language predictive of the later emergence of psychosis -- the frequent use of words associated with sound.

14 Jun 2019

$10 million endowed gift supports psychosis research efforts

Vanderbilt University Medical Center's Department of Psychiatry and Behavioral Sciences has received a $10 million endowed gift to fund translational research, support clinical programs and create an endowed chair within the department.

13 Jun 2019

Researchers develop first blood-brain barrier chip using stem cells

Researchers at Ben-Gurion University of the Negev and Cedars-Sinai Medical Center in Los Angeles have, for the first time, duplicated a patient's blood-brain barrier, creating a human BBB chip with stem cells, which can be used to develop personalized medicine and new techniques to research brain disorders.

13 Jun 2019

One in five people living in conflict-affected areas has a mental health condition, analysis reveals

New estimates from the World Health Organization highlight need for increased, sustained investment in the development of mental health services in areas affected by conflict.

12 Jun 2019

Doctors urged to prescribe woodland walks for mental health problems

The Woodland Trust says the Japanese practice of “forest bathing” should be prescribed by doctors to tackle stress and other mental health problems.

10 Jun 2019

Neuroscientists use novel technology-based tools to predict schizophrenia

Schizophrenia, a psychiatric disorder that affects about 1% of the population,is a leading cause of functional disability in the United States.

7 Jun 2019

Chronic inflammation removes motivation by reducing dopamine in the brain

Why do we feel listless when we are recovering from an illness? The answer is, apparently, that low-grade chronic inflammation interferes with the dopaminergic signaling system in the brain that motivates us to do things.

5 Jun 2019

Research on cannabis use in women limited, finds new study

A new study from the University of York shows that research into the association of psychosis with cannabis focuses almost completely on men users, significantly limiting our knowledge of the drug’s effects on human health.

5 Jun 2019

Randomized controlled trial introduces new psychotherapeutic approach to schizophrenia

A randomized controlled trial published in the current issue of Psychotherapy and Psychosomatics introduces a new psychotherapeutic approach to schizophrenia, based on psychological well-being.

31 May 2019

Long-term effects of cannabis on the adolescent brain

About one in five Canadian adolescents uses cannabis (19% of Canadians aged 15-19), and its recent legalization across the country warrants investigation into the consequence of this use on the developing brain. Adolescence

27 May 2019

Infants at high risk for autism are less attuned to differences in speech patterns

A new study by Columbia University researchers found that infants at high risk for autism were less attuned to differences in speech patterns than low-risk infants.

25 May 2019

Zebrafish embryo could help better understand the potential underpinnings of brain disorders

A close look at the rapidly developing zebrafish embryo is helping neuroscientists better understand the potential underpinnings of brain disorders, including autism and schizophrenia.

24 May 2019

Parental age linked to children's risk for neuropsychiatric disorders

Results of a new study in the Journal of the American Academy of Child and Adolescent Psychiatry, published by Elsevier, reports that parental age is linked to the risk for the development of neuropsychiatric disorders in children, including autism spectrum disorder; attention-deficit/hyperactivity disorder; obsessive-compulsive disorder; and Tourette's disorder/chronic tic disorder.

21 May 2019

Study suggests exercise as new primary prescription for psychiatric patients

When it comes to inpatient treatment of a range of mental health and mood disorders -- from anxiety and depression to schizophrenia, suicidality and acute psychotic episodes -- a new study advocates for exercise, rather than psychotropic medications, as the primary prescription and method of intervention.

21 May 2019

Study: Many patients with schizophrenia and epilepsy die before reaching the age of fifty

Patients who suffer from schizophrenia and epilepsy are particularly vulnerable. In the study, the researchers followed more than 1,5 mio. people and classified them according to whether they were diagnosed with epilepsy, schizophrenia or the combination of epilepsy and schizophrenia on their twenty-fifth birthday.

16 May 2019